Pediatrix Medical Group, Inc. $MD Shares Sold by Nomura Holdings Inc.

Key Points

• Nomura Holdings Inc. has reduced its stake in Pediatrix Medical Group by 12%, selling 35,463 shares and retaining 260,456 shares valued at approximately $3.77 million.
• Pediatrix Medical Group reported earnings per share of $0.53 for the last quarter, surpassing analyst expectations by $0.11, though revenue showed a decline of 7.1% year-over-year.
• Brokerage firm Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating, contributing to a consensus rating of "Moderate Buy" among analysts.

Nomura Holdings Inc. cut its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 12.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 260,456 shares of the company's stock after selling 35,463 shares during the period. Nomura Holdings Inc. owned about 0.30% of Pediatrix Medical Group worth $3,774,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in MD. Nuveen LLC purchased a new position in Pediatrix Medical Group in the first quarter worth about $8,024,000. Nuveen Asset Management LLC boosted its holdings in shares of Pediatrix Medical Group by 110.8% in the 4th quarter. Nuveen Asset Management LLC now owns 485,587 shares of the company's stock worth $6,371,000 after purchasing an additional 255,273 shares during the period. Teacher Retirement System of Texas increased its position in shares of Pediatrix Medical Group by 92.3% during the 1st quarter. Teacher Retirement System of Texas now owns 371,756 shares of the company's stock valued at $5,387,000 after purchasing an additional 178,386 shares during the last quarter. Northern Trust Corp raised its holdings in Pediatrix Medical Group by 18.0% during the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after buying an additional 147,522 shares during the period. Finally, Hussman Strategic Advisors Inc. bought a new position in Pediatrix Medical Group during the 1st quarter valued at about $1,217,000. Institutional investors own 97.71% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on MD shares. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. UBS Group increased their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. Finally, Leerink Partners lifted their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $16.79.

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD traded up $0.05 during trading on Friday, hitting $17.06. 1,045,640 shares of the stock traded hands, compared to its average volume of 788,504. The company has a fifty day moving average price of $14.46 and a two-hundred day moving average price of $14.11. The company has a market cap of $1.49 billion, a price-to-earnings ratio of 13.22 and a beta of 1.29. Pediatrix Medical Group, Inc. has a 52-week low of $10.06 and a 52-week high of $17.67. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.11. The business had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company's revenue for the quarter was down 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.34 EPS. As a group, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.